Justin Chakma - Net Worth and Insider Trading
Justin Chakma Net Worth
The estimated net worth of Justin Chakma is at least $2 Million dollars as of 2025-04-29. Justin Chakma is the Chief Business Officer of ARS Pharmaceuticals Inc and owns about 136,380 shares of ARS Pharmaceuticals Inc (SPRY) stock worth over $2 Million. Details can be seen in Justin Chakma's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Justin Chakma has not made any transactions after 2024-12-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Justin Chakma
Justin Chakma Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Justin Chakma owns 2 companies in total, including Silverback Therapeutics Inc (SBTX) , and ARS Pharmaceuticals Inc (SPRY) .
Click here to see the complete history of Justin Chakma’s form 4 insider trades.
Insider Ownership Summary of Justin Chakma
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| SBTX | Silverback Therapeutics Inc | 2022-11-08 | Chief Business Officer |
| SPRY | ARS Pharmaceuticals Inc | 2024-12-13 | Chief Business Officer |
Justin Chakma Latest Holdings Summary
Justin Chakma currently owns a total of 1 stock. Justin Chakma owns 136,380 shares of ARS Pharmaceuticals Inc (SPRY) as of December 13, 2024, with a value of $2 Million.
Latest Holdings of Justin Chakma
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals Inc | 2024-12-13 | 136,380 | 13.96 | 1,903,865 |
Holding Weightings of Justin Chakma
Justin Chakma Form 4 Trading Tracker
According to the SEC Form 4 filings, Justin Chakma has made a total of 5 transactions in ARS Pharmaceuticals Inc (SPRY) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in ARS Pharmaceuticals Inc is the sale of 144,605 shares on December 13, 2024, which brought Justin Chakma around $2 Million.
Insider Trading History of Justin Chakma
- 1
Justin Chakma Trading Performance
Justin Chakma Ownership Network
Ownership Network List of Justin Chakma
Ownership Network Relation of Justin Chakma
Justin Chakma Owned Company Details
What does Silverback Therapeutics Inc do?
Who are the key executives at Silverback Therapeutics Inc?
Justin Chakma is the Chief Business Officer of Silverback Therapeutics Inc. Other key executives at Silverback Therapeutics Inc include Chief Operating Officer Brian Dorsey , Chief Legal Officer Alexander A Fitzpatrick , and Chief Financial Officer Kathleen D. Scott .
Silverback Therapeutics Inc (SBTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Silverback Therapeutics Inc Insider Transactions
Justin Chakma Mailing Address
Above is the net worth, insider trading, and ownership report for Justin Chakma. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Justin Chakma's mailing address is: San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
